Outcome of Resection for Colorectal Cancer

NCT03837782 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1300

Last updated 2019-02-12

No results posted yet for this study

Summary

There are limited data from retrospective studies regarding whether short-term and long-term outcomes after laparoscopic or robot-assisted radical colectomy (minimally invasive surgery) are equivalent to those after open abdominal radical colectomy (open surgery) among patients with early and medium-stage colorectal cancer.

This trial is a multicenter,prospective, randomized trial evaluating short-term and survival outcomes concerning minimally invasive surgery and open surgery for colorectal cancer.

Conditions

  • Laparoscopy

Interventions

PROCEDURE

minimally invasive surgery

Each participating site required accreditation by the trial management committee to ensure proper surgical technique during minimally invasive surgery. No individual surgeons performed only the open approach or only the minimally invasive approach. The committee members reviewed the patients' outcomes and the videos to ensure the adequacy of the surgeon's technique.

Sponsors & Collaborators

  • Qilu Hospital of Shandong University

    collaborator OTHER
  • Zhejiang University

    collaborator OTHER
  • Peking University Cancer Hospital & Institute

    collaborator OTHER
  • Zhengzhou University

    collaborator OTHER
  • Peking Union Medical College

    collaborator OTHER
  • Sun Yat-sen University

    collaborator OTHER
  • Fudan University

    collaborator OTHER
  • Shanghai Jiao Tong University School of Medicine

    collaborator OTHER
  • Massachusetts General Hospital

    collaborator OTHER
  • Harvard Medical School (HMS and HSDM)

    collaborator OTHER
  • M.D. Anderson Cancer Center

    collaborator OTHER
  • University of California, Los Angeles

    collaborator OTHER
  • University of Pennsylvania

    collaborator OTHER
  • Tianjin Medical University Cancer Institute and Hospital

    lead OTHER

Principal Investigators

  • Dalu M Kong, M.D. · Tianjin Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-15
Primary Completion
2019-11-30
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03837782 on ClinicalTrials.gov